Mipha® is the result of the collective and collaborative efforts of academic, government and industry partners, tirelessly working towards integrating Nanotechnology, Information technology, Biotechnology and Cognitive science into an easy to use m-Health app to assist you through your mobile phone, in your language, and without the need for any prior healthcare training.
Try Mipha® now to find out how you can become empowered through diagnostic tools, easy to understand tutorials and a friendly reassuring step-by-step guide to your health and the health of the environment around you.
Empowering health workers and you at home or work.
Mipha® assists you to collect rapid test kit results, including unconfirmed but suspected cases, which allows for early warning notification and rapid intervention. Government health departments are provided with a dashboard, displaying real-time results of suspected cases and confirmed cases of diseases supported by Mipha. There are also built in e-health tutorials to help you learn more about diseases, pests and conditions that you can better understand. includes an intelligent symptom checker, that learns from experience, covering an increasing number of diseases, a real-time reporting system to record cases, as well as “REASSURED” rapid test kit integration to automatically capture confirmed results of diseases.
Mipha® assist you to collect rapid test kit results, including unconfirmed but suspected cases, to allow for early stakeholder notification and intervention. Government health departments can be provided with a dashboard, displaying real-time anonymised results of suspected cases and confirmed cases of diseases supported by the app. The app has built in e-heath tutorials for field workers, a symptom checker covering an increasing number of diseases, a real-time reporting system to record cases, as well as rapid test kit integration to automatically capture confirmed results of diseases.
You can use Mipha to store data about your health and your environment, and share this information with your health practitioner or supervisor if needed.
The Mipha® heat map function allows you to track outbreaks in your area, and be more informed of how to protect yourself in advance.
Test kits, mosquito nets, pesticides, pheromone traps and an ever-increasing list of health support materials can be ordered online and be delivered across the continent. The Mipha team has extensive logistics experience including rural Sub-Saharan Africa and has innovative ways of ensuring that goods arrive at the destination in a timely manner.
The verified results of test kits are shared anonymously on the Mipha heat maps, and also inform the intelligent symptom checker, helping to more accurately predict conditions based on multiple variable including historical data for your area and other confirmed recent results from close to your location.
Data collected in this way is also used by epidemiologists to build predictive models for future outbreaks, to allow other stakeholders to better plan preventative and outbreak responses.
Mipha helps you improve your skills
Mipha® includes training material on an increasing list of topics, to improve your skills by learning more about the diseases, pests or conditions that might affect you. A current example affecting subsistence and commercial farmers across the African continent right now, the Fall Armyworm pest in Maize. This pest is causing USD10 Billion damage per year and causing untold suffering through reduced food security. In this case Mipha can help you with:
- Scouting procedures to find the pest of interest.
- Preliminary visual identification.
- Sample preparation for test kit application.
- Capturing results with real-time Geo-location reporting
- Crop yield assessment calculator
- Crop damage assessment calculator
- Intervention management advice and coordination.
- Localized real-time reporting of the results for the farmer/agricultural worker.
The growing Mipha team and ongoing extensive collaborations with academia and industry are building an increasing library of carefully curated content available in multiple languages, to improve both the tutorial content as well as the symptom checker component of Mipha. This represents a true e-Education and e-Health initiative that can be driven by government and aligned with its intervention management program.
Mipha’s language module initially includes: English, Portuguese, French and Sesotho. More collaborations are being sought to assist with many more translations to improve accessibility especially in rural communities.
The Mipha team has extensive experience in rural broadband connectivity and under-serviced area telecommunications service delivery. The plan is to obtain buy-in from government and large telecommunications players, to allow the delivery of educational and e-Health content for free within Mipha. Mipha has been designed to also download content when at public hotspots, and then work off-line where there is no connectivity.
Alignment with (RE)ASSURED criteria for developing world diagnostics
More than 10 years ago the World Health Organization (WHO) developed the ASSURED criteria in response to the need for improved diagnostics tests.
In 2019 a group led by researchers at the CSIR, reviewed this criteria and published suggested amendments to incorporate lessons from the failings of the past 10 years and opportunities brought by new technologies to achieve these objectives. https://www.nature.com/articles/s41564-018-0295-3
Mipha is a well aligned as a powerful tool in the pursuit of delivering the REASSURED criteria goals for developing nations.
As part of Mipha’s contribution to this strategy Liselo Labs is establishing a regional diagnostics laboratory that is able to receive some of the rapid test kits used by Mipha users, collected by couriers and shipped to the lab, where results are verified by “gold standard” approved diagnostics tests (PCR, ELISA, NEUTS). Lab confirmed results will then posted back to Mipha to provide users with confirmed diagnosis/results, as well as to other stakeholders where necessary.
This intervention not only provides on-going validation rapid test kit results and accuracy but also provides WHO/OIE approved diagnostic methods/protocols for validation of the disease in question.
Mipha therefore represents a unique opportunity to enable (RE)ASSURED criteria to be deployed for legacy RDT’s as well as for emerging diagnostics kits suitable for point of care applications.